These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7705775

  • 1. Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7 alpha-hydroxylase.
    Ståhlberg D, Reihnér E, Rudling M, Berglund L, Einarsson K, Angelin B.
    Hepatology; 1995 Apr; 21(4):1025-30. PubMed ID: 7705775
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of bezafibrate on hepatic cholesterol metabolism.
    Ståhlberg D, Reihnér E, Ewerth S, Einarsson K, Angelin B.
    Eur J Clin Pharmacol; 1991 Apr; 40 Suppl 1():S33-6. PubMed ID: 2044640
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hepatic cholesterol and bile acid synthesis in Japanese patients with cholesterol gallstones.
    Honda A, Yoshida T, Tanaka N, Matsuzaki Y, He B, Osuga T, Kobayashi N, Ozawa K.
    Gastroenterol Jpn; 1993 Jun; 28(3):406-14. PubMed ID: 8344502
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
    Liang K, Vaziri ND.
    Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409
    [Abstract] [Full Text] [Related]

  • 9. In vitro studies of lipid metabolism in human liver.
    Angelin B, Reihnér E, Rudling M, Ewerth S, Björkhem I, Einarsson K.
    Am Heart J; 1987 Feb; 113(2 Pt 2):482-7. PubMed ID: 3812206
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.
    Vaziri ND, Sato T, Liang K.
    Kidney Int; 2003 May; 63(5):1756-63. PubMed ID: 12675851
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol 7alpha-hydroxylase activity.
    Hillebrant C, Nyberg B, Angelin B, Axelson M, Björkhem I, Rudling M, Einarsson C.
    J Intern Med; 1999 Oct; 246(4):399-407. PubMed ID: 10583711
    [Abstract] [Full Text] [Related]

  • 14. Effects of dietary soybean lecithin on plasma lipid transport and hepatic cholesterol metabolism in rats.
    LeBlanc MJ, Brunet S, Bouchard G, Lamireau T, Yousef IM, Gavino V, Lévy E, Tuchweber B.
    J Nutr Biochem; 2003 Jan; 14(1):40-8. PubMed ID: 12559476
    [Abstract] [Full Text] [Related]

  • 15. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.
    Roberts CK, Liang K, Barnard RJ, Kim CH, Vaziri ND.
    Kidney Int; 2004 Oct; 66(4):1503-11. PubMed ID: 15458444
    [Abstract] [Full Text] [Related]

  • 16. Cholesterol metabolism in human gallbladder mucosa: relationship to cholesterol gallstone disease and effects of chenodeoxycholic acid and ursodeoxycholic acid treatment.
    Sahlin S, Ahlberg J, Reihnér E, Ståhlberg D, Einarsson K.
    Hepatology; 1992 Aug; 16(2):320-6. PubMed ID: 1639340
    [Abstract] [Full Text] [Related]

  • 17. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients.
    Reihnér E, Angelin B, Rudling M, Ewerth S, Björkhem I, Einarsson K.
    J Lipid Res; 1990 Dec; 31(12):2219-26. PubMed ID: 2090716
    [Abstract] [Full Text] [Related]

  • 18. Hepatic cholesterol metabolism in patients with gallstones.
    Salen G, Nicolau G, Shefer S, Mosbach EH.
    Gastroenterology; 1975 Sep; 69(3):676-84. PubMed ID: 1158085
    [Abstract] [Full Text] [Related]

  • 19. Hepatic cholesterol metabolism in cholesterol gallstone disease.
    Reihnér E, Angelin B, Björkhem I, Einarsson K.
    J Lipid Res; 1991 Mar; 32(3):469-75. PubMed ID: 2066675
    [Abstract] [Full Text] [Related]

  • 20. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment.
    Ahlberg J, Angelin B, Einarsson K.
    J Lipid Res; 1981 Mar; 22(3):410-22. PubMed ID: 7240966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.